Aoife M Brennan

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Pluripotent Stem Cells

Escherichia Coli

Combination Therapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Synthetic biology (Oxford, England)

Nature metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Jason John Luke, Sarina A Piha-Paul, Theresa M Medina, Claire F Verschraegen, Mary Varterasian, Aoife M Brennan, Richard J Riese, Anna Sokolovska, James F Strauss, David L Hava, Filip Janku
Phase I study of SYNB1891, an engineered E coli Nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jason John Luke, Sarina A Piha-Paul, Theresa M Medina, Claire F Verschraegen, Mary Varterasian, Aoife M Brennan, Richard J Riese, Anna Sokolovska, James F Strauss, David L Hava, Filip Janku
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jerry Vockley, Neal Sondheimer, Marja K Puurunen, George A Diaz, Ilona Ginevic, Dorothy K Grange, Cary O Harding, Hope Northrup, John A Phillips, Shawn Searle, Janet A Thomas, Roberto Zori, William S Denney, Sharon L Ernst, Kristina Humphreys, Nicole McWhorter, Caroline B Kurtz, Aoife M Brennan
Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial. Nature metabolism (2023)
Aoife M Brennan
Development of synthetic biotics as treatment for human diseases. Synthetic biology (Oxford, England) 7 (1) (2022)